Zobrazeno 1 - 10
of 113
pro vyhledávání: '"A. G. Dinmohamed"'
Autor:
L. Van Der Straten, C. C. Maas, M.-D. Levin, O. Visser, E. F. Posthuma, J. K. Doorduin, A. W. Langerak, A. P. Kater, A. G. Dinmohamed
Publikováno v:
HemaSphere, Vol 6, Pp 1765-1766 (2022)
Externí odkaz:
https://doaj.org/article/bc5123ee905e4fa6b74c8c854b0f90d7
Autor:
Carolien C. H. M. Maas, David van Klaveren, Müjde Durmaz, Otto Visser, Djamila E. Issa, Eduardus F. M. Posthuma, Josée M. Zijlstra, Martine E. D. Chamuleau, Pieternella J. Lugtenburg, Marie José Kersten, Avinash G. Dinmohamed
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract First-line treatment for advanced-stage diffuse large B-cell lymphoma (DLBCL) typically involves 6x R-CHOP21 or 6x R-CHOP21 with two additional rituximab administrations (6x R-CHOP21 + 2 R). In contemporary practice, this treatment choice mi
Externí odkaz:
https://doaj.org/article/c4b65197aa51466bbe82400bbe7a2fb7
Autor:
Lina van derStraten, Mark‐David Levin, Manette A. W. Dinnessen, Otto Visser, Eduardus F. M. Posthuma, Jeanette K. Doorduijn, Anton W. Langerak, Arnon P. Kater, Avinash G. Dinmohamed
Publikováno v:
HemaSphere, Vol 8, Iss 11, Pp n/a-n/a (2024)
Abstract Chronic lymphocytic leukemia (CLL) manifests heterogeneously with varying outcomes. This population‐based study examined causes of death (CODs), as registered by the physician who established the death, among 20,588 CLL patients diagnosed
Externí odkaz:
https://doaj.org/article/69e8af3064e9466f885ecb842801b1fa
Autor:
Hester F Lingsma, David van Klaveren, Arjan A van de Loosdrecht, Anna van Rhenen, Otto Visser, Valery E P P Lemmens, Nikki van Leeuwen, Gerwin Huls, Z L Rana Kaplan, Eduardus F M Posthuma, Danielle van Lammeren-Venema, Tjeerd J F Snijders, Catharina H M J van Elssen, Peter A von dem Borne, Nicole M A Blijlevens, Jan J Cornelissen, Marc H G P Raaijmakers, Avinash G Dinmohamed
Publikováno v:
BMJ Oncology, Vol 3, Iss 1 (2024)
Objective Acute myeloid leukaemia (AML) prognosis is enhanced with intensive remission induction chemotherapy (ICT) in eligible patients. However, ICT eligibility perceptions may differ among healthcare professionals. This nationwide, population-base
Externí odkaz:
https://doaj.org/article/1ccfa978daa64b508cdfbda59b2174a6
Autor:
Elise R. A. Pennings, Müjde Durmaz, Otto Visser, Eduardus F. M. Posthuma, Djamila E. Issa, Martine E. D. Chamuleau, Pieternella J. Lugtenburg, Marie José Kersten, Avinash G. Dinmohamed
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-5 (2024)
Externí odkaz:
https://doaj.org/article/8f31d6c5c4d645b6acf4a936c3d76670
Autor:
A. Vera de Jonge, Erik van Werkhoven, Avinash G. Dinmohamed, Marcel Nijland, Aeilko H. Zwinderman, Patrick M. Bossuyt, Martine S. Veldhuis, Emma G. G. M. Rutten, Rogier Mous, Joost S. P. Vermaat, Yorick Sandberg, Eva de Jongh, Yavuz M. Bilgin, Rinske Boersma, Harry Koene, Marie José Kersten, Daphne de Jong, Martine E. D. Chamuleau
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Patients with MYC rearranged (MYC-R) diffuse large B-cell lymphoma (DLBCL) have a poor prognosis. Previously, we demonstrated in a single-arm phase II trial (HOVON-130) that addition of lenalidomide to R-CHOP (R2CHOP) is well-tolerated and y
Externí odkaz:
https://doaj.org/article/1442e5a628e5483589f1ebbec3e603f1
Autor:
Priscilla Kamphuis, Isabelle A. van Zeventer, Aniek O. de Graaf, Giulio Genovese, Jonas B. Salzbrunn, Avinash G. Dinmohamed, Bert A. van der Reijden, Jan Jacob Schuringa, Joop H. Jansen, Gerwin Huls
Publikováno v:
HemaSphere, Vol 7, Iss 10, p e956 (2023)
Externí odkaz:
https://doaj.org/article/afcc11b0a3ec490a80013e9d69a25b7e
Autor:
Lina van der Straten, Mark-David Levin, Manette A. W. Dinnessen, Otto Visser, Eduardus F. M. Posthuma, Jeanette K. Doorduijn, Anton W. Langerak, Arnon P. Kater, Avinash G. Dinmohamed
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract The longevity of patients with chronic lymphocytic leukemia (CLL) has improved progressively over the past decades, making it essential to understand long-term health outcomes, such as second primary malignancies (SPMs). Therefore, this nati
Externí odkaz:
https://doaj.org/article/fe5a21bbbb564ebc86aae6de741eef1b
Autor:
Maya Schulpen, Auke Beishuizen, Martine E. D. Chamuleau, Avinash G. Dinmohamed, Friederike A. G. Meyer-Wentrup, H. Josef Vormoor, Lotte E. van der Wagen, Monique C. Minnema, Jan L. C. Loeffen, Henrike E. Karim-Kos
Publikováno v:
Haematologica, Vol 109, Iss 3 (2023)
Externí odkaz:
https://doaj.org/article/e31a1c4d5d244d6cbe9601067a59d888
Autor:
Elise R.A. Pennings, Müjde Durmaz, Otto Visser, Eduardus F.M. Posthuma, Djamila E. Issa, Martine E.D. Chamuleau, Anne M. Spanjaart, Tom van Meerten, Pim G.N.J. Mutsaers, Margot Jak, Suzanne van Dorp, Joost S.P. Vermaat, Marjolein W.M. van der Poel, Maria T. Kuipers, Frederick W. Thielen, Carin A. Uyl-de Groot, Pieternella J. Lugtenburg, Marie José Kersten, Avinash G. Dinmohamed
Publikováno v:
HemaSphere, Vol 7, p e992046d (2023)
Externí odkaz:
https://doaj.org/article/2a1ce217092646aab218c2e883f0ac51